SCHEMBL27224580

SCHEMBL27224580

CCC(CC)COS(=O)(=O)[O-].[Na+]

nearest known ligand 0.43

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 2/20 0.39
CA2 known ✓ P00918 2/20 0.39
CA12 known ✓ O43570 1/20 0.39
RECQL P46063 2/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
EPHX2 P34913 1/20 0.43
BLM P54132 1/20 0.43
CA7 P43166 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27224578 0.87 CA2 (0.52) RECQLGLAHPGDTSHRMAPK1
Ethasulfuric Acid SCHEMBL57666 0.84 CYP3A4 (0.50) RECQLGLAHPGDTSHRMAPK1
Ethasulfuric Acid SCHEMBL30312334 0.84 CYP3A4 (0.50) RECQLGLAHPGDTSHRMAPK1
Ethasulfuric Acid SCHEMBL27915134 0.82 CYP3A4 (0.49) RECQLGLAHPGDTSHRMAPK1
Ethasulfuric Acid SCHEMBL2293348 0.80 CYP3A4 (0.50) RECQLGLAHPGDTSHRMAPK1
Ethasulfuric Acid SCHEMBL4595626 0.80 CYP3A4 (0.50) RECQLGLAHPGDTSHRMAPK1
Ethasulfuric Acid SCHEMBL17456529 0.80 CYP3A4 (0.50) RECQLGLAHPGDTSHRMAPK1
SCHEMBL5154099 0.77 TSHR (0.39) RECQLGLAHPGDTSHRMAPK1
SCHEMBL8343913 0.77 CA1 (0.43) RECQLCA1CA2CA12CA7
Ethasulfuric Acid SCHEMBL23387498 0.76 RECQL (0.67) RECQLGLAHPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12584032-B2 Reaction liquid and ink jet recording method CANON KABUSHIKI KAISHA (JP) 2026-03-24 US disclosed
US-20240174880-A1 REACTION LIQUID AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2024-05-30 US disclosed
EP-4375343-A1 REACTION LIQUID AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2024-05-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12584032-B2 Reaction liquid and ink jet recording method JAK1, ALK, JAK2 CA1 132/4885CA2 186/4885CA12 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.